Before medical devices, diagnostic equipment, IVDs, and healthcare products can be legally sold in India, they must comply with CDSCO regulatory requirements. We provide end-to-end registration, licensing, and AIR services — from product classification through final approval.
The Central Drugs Standard Control Organisation (CDSCO) is India’s national regulatory authority for medical devices, pharmaceuticals, diagnostics, and healthcare products. It operates under the Ministry of Health and Family Welfare and oversees product approvals, import licensing, inspections, and post-market surveillance. For manufacturers and importers, CDSCO approval is mandatory before products can be legally marketed in India.
The Central Drugs Standard Control Organisation is India’s primary healthcare regulatory body. It ensures that all products entering the Indian healthcare market meet established standards before reaching patients and healthcare providers.
CDSCO plays a critical role in safeguarding public health by regulating the safety, quality, performance, and effectiveness of medical devices and healthcare products. Its oversight extends to product approvals, licensing, import controls, inspections, and regulatory enforcement.
For any business seeking to enter India’s healthcare market, CDSCO approval is not simply a compliance requirement — it is the foundation for legal market access.
Several categories of businesses require CDSCO registration or licensing. If a product falls within the scope of India’s medical device regulations, approval is generally required before commercialization.
Companies manufacturing regulated medical devices within India for the domestic market.
Overseas companies exporting medical devices, diagnostics, or healthcare products to India.
Businesses importing medical devices and healthcare products into the Indian market through authorized channels.
Companies producing diagnostic and laboratory equipment for clinical or research use in India.
Manufacturers of in-vitro diagnostic reagents, kits, and testing systems covered under CDSCO regulations.
Businesses developing innovative medical technologies, digital health devices, and AI-enabled healthcare equipment.
Medical devices in India are regulated according to risk classification under the Medical Device Rules, 2017. Correct classification is one of the most critical steps — it determines the approval pathway, documentation requirements, review process, and licensing obligations.
Basic medical devices with minimal risk to patients. Lowest regulatory scrutiny.
Low RiskDevices presenting low to moderate levels of patient risk. Standard review pathway.
Low–Moderate RiskDevices requiring enhanced regulatory scrutiny due to moderate to high patient risk.
Moderate–High RiskCritical, high-risk devices that may significantly impact patient health and safety.
High RiskCDSCO requirements apply to a broad range of healthcare products. Because regulations continue to evolve, businesses should verify whether their specific products require registration before entering the market.
The registration process varies depending on product type, classification, manufacturing location, and intended market activity. A structured approach significantly improves approval timelines and outcomes.
Determine the appropriate device category and risk class (A, B, C, or D). Correct classification is essential — an inaccurate determination affects the entire approval pathway and can cause significant delays.
Identify the applicable regulatory pathways, documentation requirements, and licensing obligations specific to your product category and classification level.
Prepare all required technical, quality, and regulatory documents. Documentation quality is one of the most important factors influencing approval timelines — gaps at this stage frequently result in clarification requests from CDSCO.
Applications are submitted through the CDSCO online system and SUGAM platform. Required forms and supporting documentation are filed for regulatory review.
SUGAM PortalCDSCO reviews technical information and documentation. The authority may issue clarification requests or queries during this stage, which require timely and accurate responses to avoid delays.
Upon successful completion of the review process, CDSCO grants the relevant registration or license. Higher-risk products typically require more extensive review than lower-risk devices. Industry timelines range from several weeks to several months.
Foreign manufacturers intending to sell medical devices in India generally require an import license. Without the required approval, products may face customs delays, import restrictions, or market access limitations. Certain lower-risk Class A devices may follow a different registration pathway.
Key Import License Forms
Documentation requirements vary depending on the product type and approval pathway. Accurate and complete documentation is one of the most important factors influencing CDSCO approval timelines.
Many companies encounter significant challenges when navigating India’s medical device regulatory framework for the first time. Working with experienced compliance specialists helps mitigate these risks.
An inaccurate risk classification may send the application down the wrong regulatory pathway, causing delays and requiring resubmission.
Missing or incomplete technical information is among the most common causes of CDSCO clarification requests and approval delays.
Foreign manufacturers frequently encounter difficulties with Form MD-14 submissions and understanding import licensing requirements specific to their product category.
Healthcare regulations under CDSCO continue to evolve. Staying current with Medical Device Rules amendments and new regulatory guidance requires ongoing monitoring.
Selecting an inexperienced Authorized Indian Representative can create communication bottlenecks with CDSCO and significantly increase compliance risks and timelines.
CDSCO may issue technical queries during review. Timely, accurate, and well-supported responses are critical to maintaining application momentum.
Healthcare compliance demands precision, experience, and proactive regulatory management. From initial assessment to final approval, our team manages the entire CDSCO regulatory lifecycle.
Accurate risk classification under Medical Device Rules, 2017 to ensure the correct regulatory pathway from the outset.
Tailored compliance roadmap based on product type, classification, and market entry objectives.
Preparation and review of all required technical, quality, and regulatory documents for CDSCO submission.
End-to-end application management through the SUGAM portal and CDSCO online systems.
Assistance with Form MD-14 submissions and coordination of import licensing requirements for foreign manufacturers.
We act as your official regulatory liaison before CDSCO — managing all communications, correspondence, and compliance requirements.
Timely preparation and submission of responses to CDSCO clarification requests to maintain application progress.
Ongoing regulatory monitoring, renewal management, and post-market surveillance support after license issuance.
We work with organizations across the full spectrum of India’s healthcare and life sciences sector — from global medical device manufacturers to domestic importers and distributors.
Common questions from manufacturers and importers navigating CDSCO requirements for the first time.
For many regulated medical devices and healthcare products, CDSCO approval is mandatory before market entry. Whether registration is required depends on the product category and applicable regulations under the Medical Device Rules, 2017. A product classification assessment is recommended before proceeding.
An Authorized Indian Representative is an Indian entity authorized to represent foreign manufacturers before CDSCO. The AIR acts as the official regulatory liaison, managing application coordination, documentation, correspondence, and ongoing compliance requirements on behalf of the foreign manufacturer.
Form MD-14 is the application form used to request a medical device import license from CDSCO. It must be submitted through the SUGAM portal along with the required technical and regulatory documentation for the product seeking import approval.
Form MD-15 is the import license issued by CDSCO after a successful review of the Form MD-14 application. It authorizes the legal import and sale of the approved medical device in India.
Requirements depend on product classification and applicable regulatory coverage. Not all devices are currently notified under mandatory CDSCO requirements, but the regulatory scope continues to expand. Businesses should verify current obligations specific to their product before market entry.
Timelines vary depending on device category, documentation quality, and review requirements. Industry timelines typically range from several weeks to several months. Higher-risk Class C and D devices require more extensive evaluation than lower-risk products. Early preparation significantly reduces overall approval time.
Yes. Provenza India provides complete Authorized Indian Representative (AIR) services for foreign medical device manufacturers — managing all CDSCO correspondence, application coordination, documentation management, and ongoing compliance obligations.
Absolutely. We offer end-to-end CDSCO registration, licensing, and compliance services — from product classification and documentation preparation through application filing, query management, and post-approval support.
The Indian healthcare sector offers tremendous growth opportunities — but regulatory compliance is the first step toward success. Speak with our CDSCO specialists today.
© 2026 Provenza India Pvt. Ltd. | Expert BIS Consultants & Compliance Specialists.